Home Healthcare Biotechnology Coagulation Testing Market

Coagulation Testing Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables), By Test Type (Prothrombin Time (PT), Activated Partial Thromboplastin Clotting Time (APTT), Thrombin Time (TT), Activated Clotting Time (ACT), Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Coagulation Testing Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Consumables
  2. Coagulation Testing Market, By Test Type 2022-2034 (USD MILLION/ Units)
    1. Prothrombin Time (PT)
    2. Activated Partial Thromboplastin Clotting Time (APTT)
    3. Thrombin Time (TT)
    4. Activated Clotting Time (ACT)
    5. Others
  3. Coagulation Testing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Diagnostic Laboratories
    3. Home Care Settings
    4. Others
  4. Regional Coagulation Testing Market
    1. North America
      1. North America Coagulation Testing Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
      2. North America Coagulation Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Prothrombin Time (PT)
        2. Activated Partial Thromboplastin Clotting Time (APTT)
        3. Thrombin Time (TT)
        4. Activated Clotting Time (ACT)
        5. Others
      3. North America Coagulation Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Laboratories
        3. Home Care Settings
        4. Others
      4. U.S.
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      5. Canada
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
    2. Europe
      1. Europe Coagulation Testing Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
      2. Europe Coagulation Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Prothrombin Time (PT)
        2. Activated Partial Thromboplastin Clotting Time (APTT)
        3. Thrombin Time (TT)
        4. Activated Clotting Time (ACT)
        5. Others
      3. Europe Coagulation Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Laboratories
        3. Home Care Settings
        4. Others
      4. U.K.
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      5. Germany
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      6. France
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      7. Spain
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      8. Italy
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      9. Russia
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      10. Nordic
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      11. Benelux
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      12. Rest of Europe
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
    3. APAC
      1. APAC Coagulation Testing Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
      2. APAC Coagulation Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Prothrombin Time (PT)
        2. Activated Partial Thromboplastin Clotting Time (APTT)
        3. Thrombin Time (TT)
        4. Activated Clotting Time (ACT)
        5. Others
      3. APAC Coagulation Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Laboratories
        3. Home Care Settings
        4. Others
      4. China
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      5. Korea
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      6. Japan
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      7. India
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      8. Australia
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      9. Singapore
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      10. Taiwan
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      11. South East Asia
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      12. Rest of Asia-Pacific
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
    4. Middle East and Africa
      1. Middle East and Africa Coagulation Testing Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
      2. Middle East and Africa Coagulation Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Prothrombin Time (PT)
        2. Activated Partial Thromboplastin Clotting Time (APTT)
        3. Thrombin Time (TT)
        4. Activated Clotting Time (ACT)
        5. Others
      3. Middle East and Africa Coagulation Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Laboratories
        3. Home Care Settings
        4. Others
      4. UAE
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      5. Turkey
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      6. Saudi Arabia
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      7. South Africa
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      8. Egypt
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      9. Nigeria
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      10. Rest of MEA
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
    5. LATAM
      1. LATAM Coagulation Testing Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
      2. LATAM Coagulation Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Prothrombin Time (PT)
        2. Activated Partial Thromboplastin Clotting Time (APTT)
        3. Thrombin Time (TT)
        4. Activated Clotting Time (ACT)
        5. Others
      3. LATAM Coagulation Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Laboratories
        3. Home Care Settings
        4. Others
      4. Brazil
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      5. Mexico
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      6. Argentina
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      7. Chile
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      8. Colombia
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
      9. Rest of LATAM
        1. Instruments
        2. Consumables
        3. Prothrombin Time (PT)
        4. Activated Partial Thromboplastin Clotting Time (APTT)
        5. Thrombin Time (TT)
        6. Activated Clotting Time (ACT)
        7. Others
        8. Hospitals and Clinics
        9. Diagnostic Laboratories
        10. Home Care Settings
        11. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.